← Back to Search

Cholates for Liver Disease

Phase 2
Waitlist Available
Led By James Trotter, MD
Research Sponsored by Baylor Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age: 18 yr to 80 yr
End-stage liver disease patient or Living Liver Donor or Congenital Heart Disease patients
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to improve the evaluation of patients with advanced liver disease. Currently, the assessment is limited to imaging, liver function tests, and liver biopsy. However, with advancements in treatments and liver transplantation

Who is the study for?
This trial is for adults aged 18 to 80 with end-stage liver disease, living liver donors, or those with congenital heart disease. Participants must be able to give written consent and follow study rules. Only patients with severe fibrosis as shown by specific tests or clinical evidence can join.
What is being tested?
The trial is testing new quantitative liver function tests using cholates. These tests aim to better evaluate the condition of patients with advanced liver disease and could help in managing their treatment and predicting outcomes more accurately.
What are the potential side effects?
Since this trial involves diagnostic procedures rather than medications, side effects are minimal but may include discomfort or risks associated with blood draws or other non-invasive testing methods used.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 80 years old.
Select...
I have end-stage liver disease, am a living liver donor, or have congenital heart disease.
Select...
My liver disease is in an advanced stage, indicated by severe scarring.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cholates CompoundExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Baylor Research InstituteLead Sponsor
206 Previous Clinical Trials
203,225 Total Patients Enrolled
2 Trials studying Liver Failure
220 Patients Enrolled for Liver Failure
James Trotter, MDPrincipal InvestigatorBaylor Health Care System
3 Previous Clinical Trials
1,313 Total Patients Enrolled
~13 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top